BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7418953)

  • 1. beta-N-acetylglucosaminidase and beta-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy.
    Pitkänen E; Kyllästinen M; Koivula T; Hormila P
    Diabetologia; 1980 Apr; 18(4):275-8. PubMed ID: 7418953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of plasma beta-N-acetylglucosaminidase activity in experimental and clinical diabetes mellitus.
    Lee YS; Akanuma Y; Iwamoto Y; Kosaka K; Kuzuya N
    Endocrinol Jpn; 1980 Aug; 27(4):463-9. PubMed ID: 6450678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients.
    Perdichizzi G; Cucinotta D; Saitta A; Cavalieri A; Squadrito G
    Acta Diabetol Lat; 1983; 20(3):257-64. PubMed ID: 6637327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy.
    Whiting PH; Ross IS; Borthwick LJ
    Clin Chim Acta; 1979 Oct; 97(2-3):191-5. PubMed ID: 487603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum glycosidase activity in diabetes mellitus.
    Merimee TJ; Kennedy AL; Mehl TD; Rosenbloom A
    Diabetes; 1981 Feb; 30(2):115-8. PubMed ID: 6781956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta-N-acetylglucosaminidase and beta-glucuronidase activities in silicosis patients and in workers exposed to silica dust.
    Koskinen H; Järvisalo J; Pitkänen E; Mutanen P; Zitting A
    Br J Dis Chest; 1984 Jul; 78(3):217-24. PubMed ID: 6331485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine glycosidase activities in diabetes mellitus.
    Price CP; Foster KJ
    Clin Biochem; 1979 Dec; 12(6):231-3. PubMed ID: 119588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine N-acetyl-beta-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics.
    Whiting PH; Ross IS; Borthwick L
    Clin Chim Acta; 1979 Mar; 92(3):459-63. PubMed ID: 436284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A; Ricci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A follow-up study of plasma beta-N-acetylglucosaminidase activity and diabetic retinopathy--observed for 2 years.
    Lee Y; Akanuma Y; Kosaka K; Kuzuya N
    Endocrinol Jpn; 1982 Feb; 29(1):77-80. PubMed ID: 7106061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lysosomal enzyme activities in silicosis and asbestosis.
    Koskinen H; Järvisalo J; Huuskonen MS; Koivula T; Mutanen P; Pitkänen E
    Eur J Respir Dis; 1983 Apr; 64(3):182-8. PubMed ID: 6840231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum angiotensin-converting enzyme and lysosomal enzymes in tobacco workers.
    Huuskonen MS; Järvisalo J; Koskinen H; Kivistö H
    Chest; 1986 Feb; 89(2):224-8. PubMed ID: 3002724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients.
    Reglero A; Carretero MI; Cabezas JA
    Clin Chim Acta; 1980 Apr; 103(2):155-8. PubMed ID: 6245816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanism of increases of serum -glucuronidase and N-acetyl- -glucosaminidase activities in diabetes mellitus. I. Clinical experiments].
    Noguchi H
    Sapporo Igaku Zasshi; 1970; 38(5):220-33. PubMed ID: 5535642
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviour of some lysosomal enzymes in the plasma of insulin dependent diabetic patients during artificial pancreas treatment.
    Burlina AB; Goi G; Fabi A; Lombardo A; Gaburro D; Tettamanti G
    Clin Biochem; 1987 Dec; 20(6):423-7. PubMed ID: 3436039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum glycosidase activity in human hypertension.
    Simon G; Altman S
    Clin Exp Hypertens A; 1984; 6(12):2219-33. PubMed ID: 6532599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isoenzymes of serum N-acetyl-beta-D-glucosaminidase in insulin-dependent diabetic subjects].
    Clemenzia G; Persichetti S; Sagliaschi G; Gallo G; Re M; Ronchi F; Russo G; Zappi P; Scibinetti F; Amici A
    Minerva Med; 1988 Jul; 79(7):547-9. PubMed ID: 3405458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetyl-beta-D-glucosaminidase levels and the onset of diabetic microangiopathy.
    Whiting PH; Ross IS; Borthwick LJ
    Ann Clin Biochem; 1983 Jan; 20 Pt 1():15-9. PubMed ID: 6838142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
    Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M
    Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
    Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.